Elez, E., Hendlisz, A., Delaunoit, T., Sastre Valera, J., Cervantes, A., Varea, R., . . . Tabernero, J. (2016). Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.

Elez, Elena|||0000-0002-4653-6324, Alain Hendlisz, Thierry Delaunoit, Javier|||0000-0001-6538-0065 Sastre Valera, Andrés|||0000-0003-3806-3691 Cervantes, Rocío Varea, Georgia Chao, Johan Wallin, e Josep|||0000-0002-2495-8139 Tabernero. Phase II Study of Necitumumab Plus Modified FOLFOX6 As First-line Treatment in Patients With Locally Advanced or Metastatic Colorectal Cancer. 2016.

Elez, Elena|||0000-0002-4653-6324, et al. Phase II Study of Necitumumab Plus Modified FOLFOX6 As First-line Treatment in Patients With Locally Advanced or Metastatic Colorectal Cancer. 2016.